This compound is commonly utilized in the pharmaceutical industry as a chiral building block for the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring a fluorophenyl group and an amine, makes it valuable in the development of drugs targeting the central nervous system, particularly for conditions like anxiety, depression, and other psychiatric disorders. The fluorine atom enhances the molecule's binding affinity and metabolic stability, making it a key component in the design of selective serotonin reuptake inhibitors (SSRIs) and other receptor-targeted therapies. Additionally, its chiral nature allows for the creation of enantiomerically pure compounds, which are crucial for ensuring the efficacy and safety of therapeutic agents.